USRE37286E1 - Method of cleansing a protein from multivalent metal ions bound thereto - Google Patents

Method of cleansing a protein from multivalent metal ions bound thereto Download PDF

Info

Publication number
USRE37286E1
USRE37286E1 US09/410,958 US41095899A USRE37286E US RE37286 E1 USRE37286 E1 US RE37286E1 US 41095899 A US41095899 A US 41095899A US RE37286 E USRE37286 E US RE37286E
Authority
US
United States
Prior art keywords
metal ions
protein
ions
multivalent metal
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/410,958
Other languages
English (en)
Inventor
Rainer Eketorp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octapharma AG
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20376405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=USRE37286(E1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Priority to US09/410,958 priority Critical patent/USRE37286E1/en
Application granted granted Critical
Publication of USRE37286E1 publication Critical patent/USRE37286E1/en
Assigned to PFIZER HEALTH AB reassignment PFIZER HEALTH AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: PHARMACIA AKTIEBOLAG
Assigned to BIOVITRUM AB reassignment BIOVITRUM AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PFIZER HEALTH AB
Assigned to OCTAPHARMA AG reassignment OCTAPHARMA AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOVITRUM AB
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Manufacturing Of Electric Cables (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
US09/410,958 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto Expired - Lifetime USRE37286E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/410,958 USRE37286E1 (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE8902317A SE500110C2 (sv) 1989-06-27 1989-06-27 Sätt att rena ett protein från därtill bundna flervärda metalljoner
SE8902317 1989-06-27
US07/778,870 US5229498A (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto
PCT/SE1990/000442 WO1991000290A1 (en) 1989-06-27 1990-06-20 Method of cleansing proteins
US09/410,958 USRE37286E1 (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07/778,870 Reissue US5229498A (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto

Publications (1)

Publication Number Publication Date
USRE37286E1 true USRE37286E1 (en) 2001-07-17

Family

ID=20376405

Family Applications (2)

Application Number Title Priority Date Filing Date
US07/778,870 Ceased US5229498A (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto
US09/410,958 Expired - Lifetime USRE37286E1 (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07/778,870 Ceased US5229498A (en) 1989-06-27 1990-06-20 Method of cleansing a protein from multivalent metal ions bound thereto

Country Status (13)

Country Link
US (2) US5229498A (sv)
EP (1) EP0484464B2 (sv)
JP (1) JPH0822873B2 (sv)
AT (1) ATE132905T1 (sv)
AU (1) AU632147B2 (sv)
CA (1) CA2058958C (sv)
DE (2) DE69024806T3 (sv)
DK (1) DK0484464T4 (sv)
ES (1) ES2031438T5 (sv)
FI (1) FI101151B (sv)
NO (1) NO300503B1 (sv)
SE (1) SE500110C2 (sv)
WO (1) WO1991000290A1 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011070399A1 (pt) 2009-12-07 2011-06-16 Universidade De Aveiro Cerâmicos produzidos a partir de escórias de incineração de resíduos sólidos

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5840851A (en) * 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
US5578564A (en) * 1993-07-23 1996-11-26 Somatogen, Inc. Nickel-free hemoglobin and methods for producing such hemoglobin
ES2103236B1 (es) 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6693173B2 (en) 2000-12-26 2004-02-17 Alpha Therapeutic Corporation Method to remove citrate and aluminum from proteins
GB0117879D0 (en) 2001-07-21 2001-09-12 Common Services Agency Storage of liquid compositions
EP3500588A1 (en) 2016-08-17 2019-06-26 Boehringer Ingelheim International GmbH Process for the preparation of highly concentrated liquid formulations containing biomolecules

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116948A (en) * 1975-03-24 1978-09-26 Hellmut Mittenzwei Process for removal of inorganic salts from peptide/salt-containing substances
US4256631A (en) * 1979-03-22 1981-03-17 Kowa Company, Limited Process for the preparation of immunoglobulin for intravenous administration
USRE36259E (en) 1990-04-19 1999-07-27 Bayer Corporation Preparing essentially monomeric normal human serum albumin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116948A (en) * 1975-03-24 1978-09-26 Hellmut Mittenzwei Process for removal of inorganic salts from peptide/salt-containing substances
US4256631A (en) * 1979-03-22 1981-03-17 Kowa Company, Limited Process for the preparation of immunoglobulin for intravenous administration
USRE36259E (en) 1990-04-19 1999-07-27 Bayer Corporation Preparing essentially monomeric normal human serum albumin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Welch, A.G. et al, Improvement in the Quality of Albumin Products (Stable Plasma Protein Solution) Using Ultrafiltration, XX Congress of the International Society of Blood Transfusion (British Blood Transfusion Society), London, Jul. 11-15, 1988.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011070399A1 (pt) 2009-12-07 2011-06-16 Universidade De Aveiro Cerâmicos produzidos a partir de escórias de incineração de resíduos sólidos

Also Published As

Publication number Publication date
DE69024806T3 (de) 2004-10-07
AU5946490A (en) 1991-01-17
SE8902317L (sv) 1990-12-28
JPH0822873B2 (ja) 1996-03-06
ES2031438T3 (es) 1996-03-16
DE69024806T2 (de) 1996-05-23
AU632147B2 (en) 1992-12-17
DK0484464T4 (da) 2004-05-03
FI101151B (sv) 1998-04-30
NO300503B1 (no) 1997-06-09
ES2031438T5 (es) 2004-09-16
JPH04506349A (ja) 1992-11-05
NO915101L (no) 1991-12-23
DK0484464T3 (da) 1996-02-12
EP0484464A1 (en) 1992-05-13
SE8902317D0 (sv) 1989-06-27
EP0484464B2 (en) 2004-02-11
DE484464T1 (de) 1992-08-13
CA2058958A1 (en) 1990-12-28
EP0484464B1 (en) 1996-01-10
ES2031438T1 (es) 1992-12-16
ATE132905T1 (de) 1996-01-15
DE69024806D1 (de) 1996-02-22
US5229498A (en) 1993-07-20
FI916000A0 (fi) 1991-12-19
WO1991000290A1 (en) 1991-01-10
SE500110C2 (sv) 1994-04-18
NO915101D0 (no) 1991-12-23
CA2058958C (en) 2000-12-12

Similar Documents

Publication Publication Date Title
JP4476362B2 (ja) 生物学的に活性なペプチドのミルクからの精製
USRE37286E1 (en) Method of cleansing a protein from multivalent metal ions bound thereto
EP0954528B2 (en) A method for chromatographic removal of prions
CA2192683C (en) Filtration
KR101528970B1 (ko) 항체의 농축 방법 및 이의 치료용 생성물
JP2553180B2 (ja) 乳清からのラクトペルオキシダーゼおよびラクトフェリンの純粋な画分の抽出法
CN110526982A (zh) 一种人胰高血糖素样肽-1类似物融合蛋白的纯化方法
DE2801123A1 (de) Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss- praeparates
EP2072056B1 (en) Process for obtaining high efficiency human albumin for use in detoxification therapy
AU2005223418B2 (en) Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing same
GB2179947A (en) Process for the extraction of proteins from milk
US4764279A (en) Process for preparing the principal proteins of hemolyzed blood in the non-denatured form
EP3362464B1 (en) Methods for extracting proteins from blood plasma
JP3009242B2 (ja) 精製単量体健康人血清アルブミン（ヒト）
JP2007509145A (ja) 天然テアニンの抽出物を濃縮するための方法
EP3418290A1 (en) Contaminant removal method
JP2002528242A (ja) 生体分子の除去及び浄化用吸着性ゲルの使用
CN110678481B (zh) 用于纯化白蛋白的方法
US20040251202A1 (en) Method of separating protein from animal milk
JP2008534687A (ja) タンパク性物質からタンパク質を単離するための高分離方法及び沈殿試薬
Zondek et al. The preparation of concentrated antigonadotropic factor (antiprolan)

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: PFIZER HEALTH AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:PHARMACIA AKTIEBOLAG;REEL/FRAME:016263/0753

Effective date: 20041020

AS Assignment

Owner name: BIOVITRUM AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PFIZER HEALTH AB;REEL/FRAME:016274/0340

Effective date: 20050427

AS Assignment

Owner name: OCTAPHARMA AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOVITRUM AB;REEL/FRAME:016283/0261

Effective date: 20050513